PACIRA PHARMACEUTICALS INC shareholders Q3 2023

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

PACIRA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AFFINITY INVESTMENT ADVISORS, LLC 9,745$298,9770.19%
HAP Trading, LLC 149,500$1,203,4750.19%
Premier Fund Managers Ltd 127,843$3,9430.18%
CORNERCAP INVESTMENT COUNSEL INC 31,007$951,2950.17%
PDT Partners, LLC 44,229$1,356,9460.17%
HUSSMAN STRATEGIC ADVISORS, INC. 26,000$797,6800.15%
EASTERLY INVESTMENT PARTNERS LLC 37,850$1,161,2380.13%
DUALITY ADVISERS, LP 32,588$999,8000.12%
Retirement Planning Co of New England, Inc. 6,590$202,1810.11%
ROTHSCHILD INVESTMENT LLC /IL 40,084$1,2300.10%
SCOUT INVESTMENTS, INC. 148,644$4,438,5090.10%
NFJ INVESTMENT GROUP, LLC 113,074$3,469,1100.10%
CAMPBELL NEWMAN ASSET MANAGEMENT INC 34,585$1,061,0680.10%
AIA Group Ltd 64,391$1,975,5160.10%
NICHOLAS COMPANY, INC. 154,330$4,734,8440.10%
SHERBROOKE PARK ADVISERS LLC 8,951$274,6170.09%
Gradient Investments LLC 105,226$3,228,3340.08%
Renaissance Technologies 1,613,997$49,5170.08%
Van Hulzen Asset Management, LLC 31,641$9710.08%
XTX Topco Ltd 13,588$416,8800.07%
External links

This page lists PACIRA PHARMACEUTICALS INC's shareholders in Q3 2023. To view PACIRA PHARMACEUTICALS INC's shareholder history, click here.